HCW Biologics Inc.
Balance Sheet
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Assets | |||||||
| Cash & Equivalents | $2.0M | $4.7M | $3.6M | $22.3M | $11.7M | $8.5M | $7.4M |
| Accounts Receivable | $32.2K | $582.2K | $1.5M | $417.7K | $133.0K | $2.5M | — |
| Inventory | — | — | — | — | — | — | — |
| Total Current Assets | $2.3M | $5.7M | $6.4M | $34.1M | $40.5M | $12.1M | — |
| Property, Plant & Equipment | $20.9M | $22.9M | $20.5M | $10.8M | $1.1M | $1.6M | — |
| Goodwill | — | — | — | — | — | — | — |
| Intangible Assets (Excl. Goodwill) | — | — | — | — | — | — | — |
| Total Assets | $24.5M | $30.2M | $28.5M | $46.8M | $53.5M | $15.4M | — |
| Liabilities | |||||||
| Accounts Payable | $13.1M | $22.3M | $6.2M | $1.2M | $223.7K | $155.3K | — |
| Total Current Liabilities | $21.1M | $29.6M | $8.7M | $3.0M | $2.3M | $1.0M | — |
| Long-Term Debt | $0 | $7.4M | $6.3M | $6.4M | $0 | — | — |
| Total Liabilities | $21.8M | $37.0M | $15.1M | $9.4M | $2.3M | $32.1M | — |
| Stockholders' Equity | |||||||
| Retained Earnings | $-108.5M | $-100.6M | $-70.5M | $-45.5M | $-30.6M | $-16.7M | — |
| Total Stockholders' Equity | $2.8M | $-6.8M | $13.5M | $37.4M | $51.2M | $-16.7M | $-9.7M |